This symposium will include presentations on weekly insulins on the horizon, oral insulins, glucose-sensitive insulin, and the role of biosimilars and interchangeable insulins. The session will begin at 8:00 a.m. on Monday in Great Hall A at the convention center. A livestream and on-demand recording are available at ADA2022.org.